Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L Riley

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
The Journal of Clinical Investigation|May 1, 2024
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replicationPablo Tebas, Julie K Jadlowsky, Pamela A Shaw, et al.
Science Translational Medicine|August 9, 2013
Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cellsBrian J Cameron, Andrew B Gerry, Joseph Dukes, et al.
Nature Immunology|August 16, 2011
Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiationMarc Beyer, Yasser Thabet, Roman-Ulrich Müller, et al.
Nature Medicine|September 8, 2020
Recommendations for measuring HIV reservoir size in cure-directed clinical trialsMohamed Abdel-Mohsen, Douglas Richman, Robert F Siliciano, et al.
Science Translational Medicine|August 31, 2022
Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapyGloria B Kim, Jens Fritsche, Sebastian Bunk, et al.
The Journal of Clinical Investigation|June 14, 2016
Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethalityAsim Saha, Roddy S O'Connor, Govindarajan Thangavelu, et al.
Nature Medicine|January 20, 2025
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapiesJulie K Jadlowsky, Elizabeth O Hexner, Amy Marshall, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
The Journal of Clinical Investigation|May 1, 2024
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replicationPablo Tebas, Julie K Jadlowsky, Pamela A Shaw, et al.
Science Translational Medicine|August 9, 2013
Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cellsBrian J Cameron, Andrew B Gerry, Joseph Dukes, et al.
Nature Immunology|August 16, 2011
Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiationMarc Beyer, Yasser Thabet, Roman-Ulrich Müller, et al.
Nature Medicine|September 8, 2020
Recommendations for measuring HIV reservoir size in cure-directed clinical trialsMohamed Abdel-Mohsen, Douglas Richman, Robert F Siliciano, et al.
Science Translational Medicine|August 31, 2022
Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapyGloria B Kim, Jens Fritsche, Sebastian Bunk, et al.
The Journal of Clinical Investigation|June 14, 2016
Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethalityAsim Saha, Roddy S O'Connor, Govindarajan Thangavelu, et al.
Nature Medicine|January 20, 2025
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapiesJulie K Jadlowsky, Elizabeth O Hexner, Amy Marshall, et al.
Pageof 13